摘要
Background The feasibility and efficacy of low-protein diets (LPD) treatment in chronic kidney disease (CKD) is controversial. Based on the characteristics of the Chinese diet, we observe the qualification rates and short-term clinical effects of LPD for CKD patients in our center. Methods This is a retrospective cohort study. CKD stages 3-5 patients who were regularly followed up 5 times (over 2 years) and treated with LPD were included. We collected clinical data to observe the changes in LPD qualification rates and divided patients into LPD and non-LPD group according to the average dietary protein intake (DPI) of 5 follow-up time points and compared the changes in primary and secondary outcome measures between the two groups. Results We analyzed data from 161 eligible CKD stages 3-5 patients. From baseline to the 5th follow-up time point, the LPD qualification rates of all patients were 11.80%, 35.40%, 47.82%, 53.43% and 54.04%, respectively. For primary outcome measures, the urine protein/creatinine ratio (UPCR) decreased more in the LPD group than in the non-LPD group [Median (interquartile range, IQR) of the difference between the 5th follow-up time point and baseline: 0.19 (- 0.01-0.73) vs. 0.10 (- 0.08-0.27), P < 0.001]. We constructed three classes of mixed linear models (model I, II, III). The UPCR slopes were all negative in the LPD group and positive in the non-LPD group (P < 0.001). Meanwhile, in model I, the estimate glomerular filtration rate(eGFR) decline slope in the LPD group was lower than that in the non-LPD group [slope (standard error): - 1.32 (0.37) vs. - 2.35 (0.33), P = 0.036]. For secondary outcome measures, body mass index (BMI) triglycerides (TG), body weight, and fat free mass (FFM) showed stable statistical differences in the comparison of LPD and non-LPD groups, with greater declines in the former. Conclusion The results of this study suggest that LPD treatment can reduce UPCR in patients with CKD stages 3-5, and may also delay the decline in eGFR. Meanwhile, it also reduces BMI, TG, body weight, and FFM, thus the need to prevent malnutrition in clinical implementation.
学科与关键词
- Diabetic Kidney Disease Benefits from Intensive Low-Protein Diet: Updated Systematic Review and Meta-analysisLi, Qiuling; Wen, Feng; Wang, Yanhui; Li, Sheng; Lin, Shaochun; Qi, Chunfang; Chen, Zujiao; Qiu, Xueqian; Zhang, Yifan; Zhang, Shaogui; Tao, Yiming; Feng, Zhonglin; Li, Zhilian; Li, Ruizhao; Ye, Zhiming; Liang, Xinling; Liu, Shuangxin; Xie, Jianteng; Wang, Wenjian*Diabetes Therapy, 2021, 12(1): 21-36.被引 15
- An Exploratory Study on a New Method for Nutritional Status Assessment in Patients with Chronic Kidney DiseaseLuo, Yayong; Huang, Hui; Wang, Qian; Lin, Wenwen; Duan, Shuwei; Zhou, Jianhui; Huang, Jing; Zhang, Weiguang; Zheng, Ying; Tang, Li; Cao, Xueying; Yang, Jian; Zhang, Li; Wang, Yong; Wu, Jie; Cai, Guangyan; Dong, Zheyi*; Chen, Xiangmei*OncoImmunology, 2023, 15(11): 2640.被引 1
- Time-restricted feeding's effect on overweight and obese patients with chronic kidney disease stages 3-4: A prospective non-randomized control pilot studyLao, Bei-ni; Luo, Jiang-hong; Xu, Xue-yi; Fu, Li-zhe; Tang, Fang; Ouyang, Wen-wei; Xu, Xin-zhu; Wei, Meng-ting; Xiao, Bing-jie; Chen, Lin-yi; Wu, Yi-fan*; Liu, Xu-sheng*Frontiers in Endocrinology, 2023, 14: 1096093.被引 2
